The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Molecule Drug CDMO Services Market Research Report 2024
Synopsis
Small molecule drug CDMO services refer to outsourcing services for the development and production of small molecule drugs. CDMO (Contract Development and Manufacturing Organization) is a third-party organization that specializes in drug development and production. It provides customized services to pharmaceutical companies, covering the entire process from the drug development stage to the commercial production stage. CDMO services for small molecule drugs usually include drug development support, clinical trial support, production process optimization, commercial production, quality control and compliance support. By choosing CDMO services, pharmaceutical companies can focus on their core business and outsource drug R&D and production to professional organizations, thereby improving efficiency, reducing risks, and accelerating the launch of new drugs.
The global Small Molecule Drug CDMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of during the forecast period 2024-2030.
North American market for Small Molecule Drug CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule Drug CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule Drug CDMO Services in Clinical Treatment is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule Drug CDMO Services include Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, Pfizer, Polypeptide, Bachem, Merck, Asymchem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMO Services.
The Small Molecule Drug CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Drug CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Drug CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Thermo Fisher Scientific
Zhejiang Jiuzhou Pharmaceutical
Porton Fine Chemicals
Lonza Group
JOINN Biologics
Zhejiang Langhua Pharmaceutical
Kingchem (Liaoning) Life Science
Segment by Type
Preparation
Chemical API
Segment by Application
Clinical Treatment
Medical Research
Commercial Production
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Drug CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Small molecule drug CDMO services refer to outsourcing services for the development and production of small molecule drugs. CDMO (Contract Development and Manufacturing Organization) is a third-party organization that specializes in drug development and production. It provides customized services to pharmaceutical companies, covering the entire process from the drug development stage to the commercial production stage. CDMO services for small molecule drugs usually include drug development support, clinical trial support, production process optimization, commercial production, quality control and compliance support. By choosing CDMO services, pharmaceutical companies can focus on their core business and outsource drug R&D and production to professional organizations, thereby improving efficiency, reducing risks, and accelerating the launch of new drugs.
The global Small Molecule Drug CDMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of during the forecast period 2024-2030.
North American market for Small Molecule Drug CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule Drug CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule Drug CDMO Services in Clinical Treatment is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule Drug CDMO Services include Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, Pfizer, Polypeptide, Bachem, Merck, Asymchem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMO Services.
The Small Molecule Drug CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Drug CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Drug CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Thermo Fisher Scientific
Zhejiang Jiuzhou Pharmaceutical
Porton Fine Chemicals
Lonza Group
JOINN Biologics
Zhejiang Langhua Pharmaceutical
Kingchem (Liaoning) Life Science
Segment by Type
Preparation
Chemical API
Segment by Application
Clinical Treatment
Medical Research
Commercial Production
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Drug CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preparation
1.2.3 Chemical API
1.3 Market by Application
1.3.1 Global Small Molecule Drug CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Treatment
1.3.3 Medical Research
1.3.4 Commercial Production
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug CDMO Services Market Perspective (2019-2030)
2.2 Global Small Molecule Drug CDMO Services Growth Trends by Region
2.2.1 Global Small Molecule Drug CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Molecule Drug CDMO Services Historic Market Size by Region (2019-2024)
2.2.3 Small Molecule Drug CDMO Services Forecasted Market Size by Region (2025-2030)
2.3 Small Molecule Drug CDMO Services Market Dynamics
2.3.1 Small Molecule Drug CDMO Services Industry Trends
2.3.2 Small Molecule Drug CDMO Services Market Drivers
2.3.3 Small Molecule Drug CDMO Services Market Challenges
2.3.4 Small Molecule Drug CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug CDMO Services Players by Revenue
3.1.1 Global Top Small Molecule Drug CDMO Services Players by Revenue (2019-2024)
3.1.2 Global Small Molecule Drug CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule Drug CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drug CDMO Services Revenue
3.4 Global Small Molecule Drug CDMO Services Market Concentration Ratio
3.4.1 Global Small Molecule Drug CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug CDMO Services Revenue in 2023
3.5 Global Key Players of Small Molecule Drug CDMO Services Head office and Area Served
3.6 Global Key Players of Small Molecule Drug CDMO Services, Product and Application
3.7 Global Key Players of Small Molecule Drug CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Drug CDMO Services Breakdown Data by Type
4.1 Global Small Molecule Drug CDMO Services Historic Market Size by Type (2019-2024)
4.2 Global Small Molecule Drug CDMO Services Forecasted Market Size by Type (2025-2030)
5 Small Molecule Drug CDMO Services Breakdown Data by Application
5.1 Global Small Molecule Drug CDMO Services Historic Market Size by Application (2019-2024)
5.2 Global Small Molecule Drug CDMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Molecule Drug CDMO Services Market Size (2019-2030)
6.2 North America Small Molecule Drug CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Molecule Drug CDMO Services Market Size by Country (2019-2024)
6.4 North America Small Molecule Drug CDMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug CDMO Services Market Size (2019-2030)
7.2 Europe Small Molecule Drug CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Molecule Drug CDMO Services Market Size by Country (2019-2024)
7.4 Europe Small Molecule Drug CDMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug CDMO Services Market Size (2019-2030)
8.2 Asia-Pacific Small Molecule Drug CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Drug CDMO Services Market Size (2019-2030)
9.2 Latin America Small Molecule Drug CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Molecule Drug CDMO Services Market Size by Country (2019-2024)
9.4 Latin America Small Molecule Drug CDMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug CDMO Services Market Size (2019-2030)
10.2 Middle East & Africa Small Molecule Drug CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gliead
11.1.1 Gliead Company Details
11.1.2 Gliead Business Overview
11.1.3 Gliead Small Molecule Drug CDMO Services Introduction
11.1.4 Gliead Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.1.5 Gliead Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Small Molecule Drug CDMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vertex
11.3.1 Vertex Company Details
11.3.2 Vertex Business Overview
11.3.3 Vertex Small Molecule Drug CDMO Services Introduction
11.3.4 Vertex Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.3.5 Vertex Recent Development
11.4 Mirati Therapeutics
11.4.1 Mirati Therapeutics Company Details
11.4.2 Mirati Therapeutics Business Overview
11.4.3 Mirati Therapeutics Small Molecule Drug CDMO Services Introduction
11.4.4 Mirati Therapeutics Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.4.5 Mirati Therapeutics Recent Development
11.5 AMPAC
11.5.1 AMPAC Company Details
11.5.2 AMPAC Business Overview
11.5.3 AMPAC Small Molecule Drug CDMO Services Introduction
11.5.4 AMPAC Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.5.5 AMPAC Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Small Molecule Drug CDMO Services Introduction
11.6.4 Pfizer Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Polypeptide
11.7.1 Polypeptide Company Details
11.7.2 Polypeptide Business Overview
11.7.3 Polypeptide Small Molecule Drug CDMO Services Introduction
11.7.4 Polypeptide Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.7.5 Polypeptide Recent Development
11.8 Bachem
11.8.1 Bachem Company Details
11.8.2 Bachem Business Overview
11.8.3 Bachem Small Molecule Drug CDMO Services Introduction
11.8.4 Bachem Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.8.5 Bachem Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Small Molecule Drug CDMO Services Introduction
11.9.4 Merck Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Asymchem
11.10.1 Asymchem Company Details
11.10.2 Asymchem Business Overview
11.10.3 Asymchem Small Molecule Drug CDMO Services Introduction
11.10.4 Asymchem Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.10.5 Asymchem Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Small Molecule Drug CDMO Services Introduction
11.11.4 Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.13 Porton Fine Chemicals
11.13.1 Porton Fine Chemicals Company Details
11.13.2 Porton Fine Chemicals Business Overview
11.13.3 Porton Fine Chemicals Small Molecule Drug CDMO Services Introduction
11.13.4 Porton Fine Chemicals Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.13.5 Porton Fine Chemicals Recent Development
11.14 Lonza Group
11.14.1 Lonza Group Company Details
11.14.2 Lonza Group Business Overview
11.14.3 Lonza Group Small Molecule Drug CDMO Services Introduction
11.14.4 Lonza Group Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.14.5 Lonza Group Recent Development
11.15 JOINN Biologics
11.15.1 JOINN Biologics Company Details
11.15.2 JOINN Biologics Business Overview
11.15.3 JOINN Biologics Small Molecule Drug CDMO Services Introduction
11.15.4 JOINN Biologics Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.15.5 JOINN Biologics Recent Development
11.16 Zhejiang Langhua Pharmaceutical
11.16.1 Zhejiang Langhua Pharmaceutical Company Details
11.16.2 Zhejiang Langhua Pharmaceutical Business Overview
11.16.3 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Introduction
11.16.4 Zhejiang Langhua Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.16.5 Zhejiang Langhua Pharmaceutical Recent Development
11.17 Kingchem (Liaoning) Life Science
11.17.1 Kingchem (Liaoning) Life Science Company Details
11.17.2 Kingchem (Liaoning) Life Science Business Overview
11.17.3 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Introduction
11.17.4 Kingchem (Liaoning) Life Science Revenue in Small Molecule Drug CDMO Services Business (2019-2024)
11.17.5 Kingchem (Liaoning) Life Science Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Small Molecule Drug CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Preparation
Table 3. Key Players of Chemical API
Table 4. Global Small Molecule Drug CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Small Molecule Drug CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Small Molecule Drug CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Small Molecule Drug CDMO Services Market Share by Region (2019-2024)
Table 8. Global Small Molecule Drug CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Small Molecule Drug CDMO Services Market Share by Region (2025-2030)
Table 10. Small Molecule Drug CDMO Services Market Trends
Table 11. Small Molecule Drug CDMO Services Market Drivers
Table 12. Small Molecule Drug CDMO Services Market Challenges
Table 13. Small Molecule Drug CDMO Services Market Restraints
Table 14. Global Small Molecule Drug CDMO Services Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Small Molecule Drug CDMO Services Market Share by Players (2019-2024)
Table 16. Global Top Small Molecule Drug CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO Services as of 2023)
Table 17. Ranking of Global Top Small Molecule Drug CDMO Services Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Small Molecule Drug CDMO Services Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Small Molecule Drug CDMO Services, Headquarters and Area Served
Table 20. Global Key Players of Small Molecule Drug CDMO Services, Product and Application
Table 21. Global Key Players of Small Molecule Drug CDMO Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule Drug CDMO Services Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Small Molecule Drug CDMO Services Revenue Market Share by Type (2019-2024)
Table 25. Global Small Molecule Drug CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Small Molecule Drug CDMO Services Revenue Market Share by Type (2025-2030)
Table 27. Global Small Molecule Drug CDMO Services Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Small Molecule Drug CDMO Services Revenue Market Share by Application (2019-2024)
Table 29. Global Small Molecule Drug CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Small Molecule Drug CDMO Services Revenue Market Share by Application (2025-2030)
Table 31. North America Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Small Molecule Drug CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Small Molecule Drug CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Small Molecule Drug CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Small Molecule Drug CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Small Molecule Drug CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Small Molecule Drug CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Small Molecule Drug CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. Gliead Company Details
Table 47. Gliead Business Overview
Table 48. Gliead Small Molecule Drug CDMO Services Product
Table 49. Gliead Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 50. Gliead Recent Development
Table 51. Boehringer Ingelheim Company Details
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Small Molecule Drug CDMO Services Product
Table 54. Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 55. Boehringer Ingelheim Recent Development
Table 56. Vertex Company Details
Table 57. Vertex Business Overview
Table 58. Vertex Small Molecule Drug CDMO Services Product
Table 59. Vertex Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 60. Vertex Recent Development
Table 61. Mirati Therapeutics Company Details
Table 62. Mirati Therapeutics Business Overview
Table 63. Mirati Therapeutics Small Molecule Drug CDMO Services Product
Table 64. Mirati Therapeutics Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 65. Mirati Therapeutics Recent Development
Table 66. AMPAC Company Details
Table 67. AMPAC Business Overview
Table 68. AMPAC Small Molecule Drug CDMO Services Product
Table 69. AMPAC Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 70. AMPAC Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Small Molecule Drug CDMO Services Product
Table 74. Pfizer Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Polypeptide Company Details
Table 77. Polypeptide Business Overview
Table 78. Polypeptide Small Molecule Drug CDMO Services Product
Table 79. Polypeptide Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 80. Polypeptide Recent Development
Table 81. Bachem Company Details
Table 82. Bachem Business Overview
Table 83. Bachem Small Molecule Drug CDMO Services Product
Table 84. Bachem Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 85. Bachem Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Small Molecule Drug CDMO Services Product
Table 89. Merck Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Asymchem Company Details
Table 92. Asymchem Business Overview
Table 93. Asymchem Small Molecule Drug CDMO Services Product
Table 94. Asymchem Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 95. Asymchem Recent Development
Table 96. Thermo Fisher Scientific Company Details
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Small Molecule Drug CDMO Services Product
Table 99. Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 100. Thermo Fisher Scientific Recent Development
Table 101. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 102. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 103. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product
Table 104. Zhejiang Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 106. Porton Fine Chemicals Company Details
Table 107. Porton Fine Chemicals Business Overview
Table 108. Porton Fine Chemicals Small Molecule Drug CDMO Services Product
Table 109. Porton Fine Chemicals Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 110. Porton Fine Chemicals Recent Development
Table 111. Lonza Group Company Details
Table 112. Lonza Group Business Overview
Table 113. Lonza Group Small Molecule Drug CDMO Services Product
Table 114. Lonza Group Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 115. Lonza Group Recent Development
Table 116. JOINN Biologics Company Details
Table 117. JOINN Biologics Business Overview
Table 118. JOINN Biologics Small Molecule Drug CDMO Services Product
Table 119. JOINN Biologics Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 120. JOINN Biologics Recent Development
Table 121. Zhejiang Langhua Pharmaceutical Company Details
Table 122. Zhejiang Langhua Pharmaceutical Business Overview
Table 123. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product
Table 124. Zhejiang Langhua Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 125. Zhejiang Langhua Pharmaceutical Recent Development
Table 126. Kingchem (Liaoning) Life Science Company Details
Table 127. Kingchem (Liaoning) Life Science Business Overview
Table 128. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product
Table 129. Kingchem (Liaoning) Life Science Revenue in Small Molecule Drug CDMO Services Business (2019-2024) & (US$ Million)
Table 130. Kingchem (Liaoning) Life Science Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Small Molecule Drug CDMO Services Picture
Figure 2. Global Small Molecule Drug CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Small Molecule Drug CDMO Services Market Share by Type: 2023 VS 2030
Figure 4. Preparation Features
Figure 5. Chemical API Features
Figure 6. Global Small Molecule Drug CDMO Services Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Small Molecule Drug CDMO Services Market Share by Application: 2023 VS 2030
Figure 8. Clinical Treatment Case Studies
Figure 9. Medical Research Case Studies
Figure 10. Commercial Production Case Studies
Figure 11. Small Molecule Drug CDMO Services Report Years Considered
Figure 12. Global Small Molecule Drug CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Small Molecule Drug CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Small Molecule Drug CDMO Services Market Share by Region: 2023 VS 2030
Figure 15. Global Small Molecule Drug CDMO Services Market Share by Players in 2023
Figure 16. Global Top Small Molecule Drug CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO Services as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Small Molecule Drug CDMO Services Revenue in 2023
Figure 18. North America Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Small Molecule Drug CDMO Services Market Share by Country (2019-2030)
Figure 20. United States Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Small Molecule Drug CDMO Services Market Share by Country (2019-2030)
Figure 24. Germany Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Small Molecule Drug CDMO Services Market Share by Region (2019-2030)
Figure 32. China Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Small Molecule Drug CDMO Services Market Share by Country (2019-2030)
Figure 40. Mexico Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Small Molecule Drug CDMO Services Market Share by Country (2019-2030)
Figure 44. Turkey Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Small Molecule Drug CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Gliead Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 49. Vertex Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 50. Mirati Therapeutics Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 51. AMPAC Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 52. Pfizer Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 53. Polypeptide Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 54. Bachem Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 56. Asymchem Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 58. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 59. Porton Fine Chemicals Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 60. Lonza Group Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 61. JOINN Biologics Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 62. Zhejiang Langhua Pharmaceutical Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 63. Kingchem (Liaoning) Life Science Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
